The Scientist

» public health and microbiology

Most Recent

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

6 Comments

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: FDA: Screen All US Blood Donations for Zika

FDA: Screen All US Blood Donations for Zika

By | August 29, 2016

The US Food and Drug Administration recommends that all blood collected across the country be tested for the virus.

0 Comments

image: Zika Update

Zika Update

By | August 24, 2016

More locally acquired cases in Florida; fetal brain damage investigated

0 Comments

image: Zika Update

Zika Update

By | August 17, 2016

More local transmission within the U.S.; babies born with costly birth defects; virus persists in a patient’s semen for six months

0 Comments

image: US Government: Zika in Puerto Rico a Public Health Emergency

US Government: Zika in Puerto Rico a Public Health Emergency

By | August 16, 2016

Local officials can now apply for additional federal funding to help slow the spread of Zika virus.

0 Comments

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: FDA: GM Mosquitoes Safe for Environment

FDA: GM Mosquitoes Safe for Environment

By | August 5, 2016

Other government authorities have yet to evaluate a proposal aimed at reducing populations of Zika-carrying insects in Florida.

3 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland